Clik here to view.
Allena Pharmaceuticals to Present at the 2016 Jefferies Healthcare Conference
Thursday, June 2nd 2016 at 2:32pm UTC NEWTON, Mass.–(BUSINESS WIRE)– Allena Pharmaceuticals, a specialty biopharmaceutical company focused on developing and commercializing non-systemic protein...
View ArticleClik here to view.
GlycoMimetics to Present at Jefferies 2016 Healthcare Conference
Thursday, June 2nd 2016 at 1:00pm UTC ROCKVILLE, Md.–(BUSINESS WIRE)– GlycoMimetics, Inc. (NASDAQ: GLYC) today announced that Chief Financial Officer Brian Hahn will provide a company overview at the...
View ArticleClik here to view.
Scholar Rock to Present at Jefferies 2016 Healthcare Conference
Friday, June 3rd 2016 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Scholar Rock, a biotechnology company focused on discovering and developing drugs that selectively target supracellular...
View ArticleClik here to view.
Arrowhead Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference
Friday, June 3rd 2016 at 11:30am UTC PASADENA, Calif.–(BUSINESS WIRE)– Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that chief operating officer and head of R&D Bruce Given, M.D.,...
View ArticleClik here to view.
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
Thursday, June 2nd 2016 at 8:05pm UTC BEDFORD, Mass.–(BUSINESS WIRE)– Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative...
View ArticleClik here to view.
Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2016 Results...
Friday, June 3rd 2016 at 8:25pm UTC NEW YORK–(BUSINESS WIRE)– Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2016 third quarter results, Wednesday, June 8, 2016, at 8:30...
View ArticleClik here to view.
Pfizer Presents Data from Phase 1b Trial Investigating Utomilumab (a 4-1BB...
Saturday, June 4th 2016 at 12:00pm UTC Oral ASCO Presentation Shows Encouraging Safety Data and Increased Support for Novel Immunotherapy Combinations NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE)...
View ArticleClik here to view.
La Jolla Pharmaceutical Company to Provide Corporate Overview at the...
Monday, June 6th 2016 at 12:00pm UTC SAN DIEGO–(BUSINESS WIRE)– La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended...
View ArticleClik here to view.
Tolero Pharmaceuticals to Present at the Jefferies 2016 Global Healthcare...
Monday, June 6th 2016 at 5:27pm UTC SALT LAKE CITY–(BUSINESS WIRE)– Tolero Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing treatments for serious hematological diseases,...
View ArticleClik here to view.
Ironwood Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference
Monday, June 6th 2016 at 8:01pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Jefferies 2016 Healthcare Conference on...
View ArticleClik here to view.
Bristol-Myers Squibb and MD Anderson Announce New Research Collaboration in...
Tuesday, June 7th 2016 at 10:59am UTC HOUSTON & NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) and The University of Texas MD Anderson Cancer Center today announced a new...
View ArticleClik here to view.
Pfizer Announces Positive Top-Line Results from Second Phase 3 Trial of Oral...
Tuesday, June 7th 2016 at 11:00am UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) announced today top-line results from Oral Psoriatic Arthritis triaL (OPAL) Beyond, the second Phase 3 study of...
View ArticleClik here to view.
Meiogenix and Lesaffre Collaborate to Improve Industrial Yeast Strains’...
Tuesday, June 7th 2016 at 12:30pm UTC PARIS–(BUSINESS WIRE)– Meiogenix and Lesaffre enter into a collaboration agreement to develop improved industrial yeast strains using Meiogenix’s recombination...
View ArticleClik here to view.
Enzo Biochem Announces New York State Approval of New Women’s Test Based on...
Tuesday, June 7th 2016 at 12:30pm UTC AmpiProbe Candidiasis™ is Third Assay Approved in Past Year Based on an Enzo Platform and Underscores Increasing Position of Company’s Clinically Relevant...
View ArticleClik here to view.
Teva to Present at the Jefferies 2016 Healthcare Conference
Tuesday, June 7th 2016 at 12:00pm UTC JERUSALEM–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the Jefferies Healthcare Conference. Mike Derkacz...
View ArticleClik here to view.
Replicor Announces Publication of Its REP 101 and REP 102 Studies...
Tuesday, June 7th 2016 at 12:00pm UTC NEW YORK–(BUSINESS WIRE)– Replicor Inc., a privately held biopharmaceutical company targeting a cure for patients with chronic hepatitis B virus (HBV) and chronic...
View ArticleClik here to view.
Replicor annonce la publication de ses études intitulées REP 101 et REP 102...
Tuesday, June 7th 2016 at 12:00pm UTC NEW YORK–(BUSINESS WIRE)– Replicor annonce la publication de ses études intitulées REP 101 et REP 102 démontrant l’effet thérapeutique des NAP (polymères d’acides...
View ArticleClik here to view.
ArthritisPower® Preliminary Results to Be Presented at Annual European...
Wednesday, June 8th 2016 at 1:30pm UTC Studies Find Arthritis Patients Underutilized as Research Participants, But Can Speak to Essential Research Priorities UPPER NYACK, N.Y.–(BUSINESS WIRE)–...
View ArticleClik here to view.
Enzo Biochem Reports Fiscal Third Quarter Results
Wednesday, June 8th 2016 at 11:30am UTC Enzo Clinical Labs Posts Another Quarter of Double Digit Growth NEW YORK–(BUSINESS WIRE)– Enzo Biochem, Inc. (NYSE:ENZ) today reported results for the third...
View ArticleClik here to view.
ARIAD to Host Analyst & Investor Day in New York City
Wednesday, June 8th 2016 at 11:35am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will host an Analyst & Investor Day for its research...
View Article